Bristol-Myers Squibb Company (BMY)

NYSE · Healthcare · Drug Manufacturers - General
$62.61-0.48%As of 2026-11-12 · USD
Day low $62.45Day high $64.12
52-week low $45.2752-week high $68.64
Market cap
$127.97B
Sector
Healthcare
P/E (TTM)
13.9x
Dividend yield
4.01%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-12 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)54.2In the neutral range (30 to 70)
MACD (12, 26, 9)0.41Above its signal line (0.24); histogram 0.16
Bollinger %B (20, 2)64%Inside the bands (59.48 to 64.36)
SMA 2061.92Price is 1.1% above
SMA 5062.00Price is 1.0% above
SMA 20059.82Price is 4.7% above
ATR (20)2.72% of priceAverage true range per day
52-week position74%In the upper part of the 45.27 to 68.64 range

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications.

Insider filings, 90 daysNo purchases and 1 sale (about $34K).
Latest fiscal yearEnded 2025-12-31: revenue of $48.20B and an operating margin of 28.5%.

More in Drug Manufacturers - General